Position in ZTS
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$6,501
+$1,846 QoQ
Shares Held
55
+48.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fortitude Family Office, LLC holds $231,944 across 21 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
2,964 | $47,068 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
64 | $34,677 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
174 | $29,325 | |
| 4 | LQDA |
Liquidia Corp
|
327 | $26,071 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
637 | $22,084 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
249 | $15,923 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
800 | $13,848 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,500 | $11,880 |
All Filings in ZTS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,501 | 55 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $4,655 | 37 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $21,801 | 149 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $23,548 | 151 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $20,251 | 123 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $30,630 | 188 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $46,500 | 238 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $2,773 | 16 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $5,414 | 32 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $9,473 | 48 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||